Hepatitis B: all 1,662 studies
Page 16 of 17. Open to participants first (192), then studies with results posted, then the rest; newest registration first within each.
- Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis BCompletedNCT00531167Phase 4
- A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B CarriersCompletedNCT00516945Not applicable
- Phase I Study to Investigate the Safety and Efficacy of HBV DNA VaccineCompletedNCT00513968Phase 1
- Laboratory Profile of Hepatitis B and C in Users of a Reference ServiceCompletedNCT00512941
- Safety and Efficacy of SmithKline Beecham (GlaxoSmithKline [GSK]) Biologicals' Candidate Adjuvanted Vaccines (287615)CompletedNCT00508833Phase 1/2
- Safety and Efficacy Study of Clevudine Compared With Clevudine and Vaccine in Patient With HBeAg(+) Chronic HBVCompletedNCT00501124Phase 4
- A Safety and Efficacy Study of a Single or Double Dose of HEPLISAV™ Hepatitis B Vaccine in Adults With End-Stage Renal DiseaseTerminatedNCT00498212Phase 2
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496158Phase 3
- Efficacy and Safety of Clevudine Compared With Adefovir in Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B VirusTerminatedNCT00496002Phase 3
- ProAlgaZyme Novel Algae Infusion: Applications in ImmunodeficiencyCompletedNCT00493506Not applicable
- A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic ChemotherapyStatus unknownNCT00489151Not applicable
- A Research Study to Test Safety, Tolerability, and Immunogenicity of a Recombinant Hepatitis B Vaccine Manufactured With an Upgrade to the Production Process (V232-054)CompletedNCT00489099Phase 3
- Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month ScheduleCompletedNCT00480116Phase 3
- HBV-specific T-cell Immunity in Individuals With HIV/HBV Co-infectionCompletedNCT00476723
- Efficacy of Tenofovir and Emtricitabine in ARV-naive Patients With HIV/HBV Co-infectionCompletedNCT00476463Phase 2
- A Study to Test the Efficacy of the HBV Vaccine and to Look at the Prevalence of HBV InfectionCompletedNCT00476411Not applicable
- An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis BCompletedNCT00467545Phase 4
- A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Lamivudine Resistant HBeAg-Negative Chronic Hepatitis B.TerminatedNCT00460850Phase 4
- Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2Status unknownNCT00451984Phase 3
- Study Evaluating Persistence of Anti-HBs Antibodies in Uraemic Patients Receiving Henogen's HBV Vaccine, or Fendrix™CompletedNCT00445185Phase 3
- Assess Efficacy, Immune Response & Safety of 2 Doses of Oral Live Attenuated HRV Vaccine at Different Viral Concentrations in Healthy InfantsCompletedNCT00429481Phase 2
- Safety of HEPLISAV™ Hepatitis B Virus Vaccine in End-stage Kidney Failure PatientsCompletedNCT00426712Phase 1
- Persistence of Hepatitis B Antibody Levels & Immune Response to a Hepatitis B Vaccine ChallengeCompletedNCT00411697Phase 4
- Trial of Telbivudine Combination Therapy vs. Continued Adefovir MonotherapyWithdrawnNCT00409019Phase 4
- Quantification of Liver Iron Overload and Steatosis Using Magnetic Resonance ImagingCompletedNCT00401336Not applicable
- Efficacy and Tolerance of Peg-interferon Alpha 2a Added to Tenofovir and Emtricitabine in AgHBe Positive HBV-HIV Co-infected PatientsCompletedNCT00391638Phase 2/3
- Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNCT00383591Phase 3
- Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNCT00383383Phase 3
- Comparison of Adjuvanted Hepatitis B Vaccine to Double Dose of Engerix™-B in Pre- /Haemodialysis Patients Aged ≥15 YearsCompletedNCT00383227Phase 3
- Risk Assessment of Long-Haul Truck DriversCompletedNCT00381992
- A Randomized Controlled Trial of Lamivudine in Acute Hepatitis BCompletedNCT00380614Phase 4
- Immunogenicity and Safety of a DTPa-HBV-IPV/Hib Vaccine Given at 2, 3 and 4 Months of AgeCompletedNCT00376779Phase 2
- To Evaluate Immunogenicity & Safety of GSK Bio's DTPa-HBV-IPV/Hib (Mixed Vaccine) and DTPa-IPV/Hib + HBV VaccinesCompletedNCT00366366Phase 3
- KRN7000 in Chronic Hepatitis BCompletedNCT00363155Phase 1/2
- Safety and Efficacy Study of Retreated Clevudine in Chronic HBV Patients Who Received Clevudine in L-FMAU-201TerminatedNCT00362700Phase 2
- Durability of Antiviral Activity in Chronic HBV Patients Who Showed Complete Response in L-FMAU-301,302 or 303 TrialCompletedNCT00362674
- Compare the Efficacy and Safety of 48-week Treatment With Clevudine 30mg Versus Lamivudine 100mg for CHB InfectionCompletedNCT00362635Phase 3
- Safety and Antiviral Activity of Clevudine in Patients Who Have Completed the L-FMAU-301 or L-FMAU-302 TrialsTerminatedNCT00362505Phase 3
- Study of PR5I, a Pediatric Combination Vaccine With Enhanced Hepatitis B Component Given Concomitantly With Prevnar®CompletedNCT00362427Phase 2
- Long Term Effects of Peginterferon Alfa-2a Plus Ribavirin for Chronic Hepatitis C/B Co-Infection and Chronic Hepatitis CCompletedNCT00361179
- Persistence of the Immune Response to Hepatitis B in 7-9 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/HibCompletedNCT00356564Phase 4
- A Randomized Phase I Study of a Hepatitis B Antigen Combined With IMP321CompletedNCT00354861Phase 1
- A Trial To Study The Effect Of Lamivudine In Adult Patients Who Suffer From Chronic Hepatitis B AloneCompletedNCT00354653Phase 4
- Immunogenicity & Safety Study of Combined/Separate Vaccine(s) Against Common Diseases in Infants (2,4,6 Months of Age).CompletedNCT00352963Phase 3
- Genes Involved in Resistance or Susceptibility to Hepatitis B VirusCompletedNCT00342186
- Persistence of the Immune Response to Hepatitis B in 4-6 Years Old Children Previously Vaccinated With DTPa-HBV-IPV/HibCompletedNCT00335881Phase 4
- Assess Immunogenicity, Reactogenicity, Safety of a Booster of GSK Biologicals DTPw-HBV/Hib Kft Compared to DTPw-HBV/HibCompletedNCT00332566Phase 3
- Evaluate Immune Response Approximately 5 to 6 Years After Receiving Different Formulations of GSK Bio Hep B VaccineCompletedNCT00329576Phase 4
- Modified Process Hepatitis B Vaccine in Healthy Neonates (V232-056)CompletedNCT00322361Phase 2
- Compare Immunogenicity & Safety of 2 Formulations of GSK Biologicals' DTPa-HBV-IPV/Hib Vaccine Given in Healthy InfantsCompletedNCT00320463Phase 3
- Safety Study of a Vaccine Against Meningitis in Infants (2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.CompletedNCT00317187Phase 3
- A Study to Assess Antibody Persistence, Boostability & Safety in Previously Primed Subjects.CompletedNCT00317174Phase 2
- Immunogenicity & Safety Study of a Vaccine Against Meningitis in Infants (2,4,6 Months) After a Hepatitis B Birth Dose.CompletedNCT00317161Phase 3
- Safety Study of a Vaccine Against Meningitis in Infants ( 2,4 & 6 Months Age) After a Birth Dose of Hepatitis B.CompletedNCT00317135Phase 3
- Assess the Immune Response Following Primary Vaccination With GSK Biologicals' Tritanrix™-HepB/Hib-MenAC vs Tritanrix™-HepB/Hiberix™ Given at 6,10 & 14 Wks of Age to Infants Who Received Hepatitis B Vaccine at BirthCompletedNCT00317122Phase 3
- Immuno & Safety Study With 2 Formulations of DTPw-HBV/HIB When Given at Birth With Hepatitis B at 2, 4 and 6 Mths.Age.TerminatedNCT00316680Phase 3
- Immunogenicity & Safety of GSK's Combined DTPa-HBV-IPV/Hib Vaccine in Indian Infants at 2 Diff Vaccination SchedulesCompletedNCT00316147Phase 3
- Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patient With Chronic HBVTerminatedNCT00313287Phase 3
- Safety and Antiviral Activity Study of Clevudine 30 mg QD in Patients With HBeAg(-) Chronic HBVTerminatedNCT00313274Phase 3
- Safety and Efficacy Study of L-FMAU in Chronic HBV Patients of L-FMAU-201 Placebo GroupTerminatedNCT00313261Phase 2
- Multicentre Booster & Immune Memory Study of a Booster Dose of GSK Biologicals' 10-valent Pneumococcal Conjugate Vaccine or a Single Dose of 23-valent Plain Polysaccharide Vaccine in Healthy Children Aged 11-18 Mths, Previously Vaccinated in Study 103488CompletedNCT00307567Phase 2
- Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis BCompletedNCT00307242Phase 4
- Safety and Antiviral Activity of Clevudine in Patients Infected With Hepatitis B VirusTerminatedNCT00305019Phase 2
- A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Responded to Previous Hepatitis B Vaccination But Lost Antibody.CompletedNCT00291980Phase 3
- Assess Immune Response Following Primary Vaccination With Tritanrix™-HepB Vaccine Mixed With 3 Formulations of Hib-MenAC Vaccine to InfantsCompletedNCT00291967Phase 2
- Compare the Immune Response & Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine vs Aventis Pasteur MSD's Hepatitis B Vaccine in Pre-Dialysis & Dialysis Patients Who Did Not Respond to Previous Hepatitis B VaccinationCompletedNCT00291954Phase 3
- A Study to Compare the Immune Response and Safety Elicited by Henogen's Adjuvanted Hepatitis B Vaccine Compared to GSK Biologicals Adjuvanted Hepatitis B Vaccine in Pre-Dialysis and Dialysis Patients Who Have Not Been Exposed to Hepatitis B.CompletedNCT00291941Phase 3
- Efficacy Study of Thymosin alpha1 & Pegylated Interferon-alpha2a to Treat Chronic Hepatitis BCompletedNCT00291616Phase 4
- Assess if Immune Response of GSK Biologicals' Tritanrix™-HepB/Hib-MenAC Given Without or With Hepatitis B Vaccine at Birth is at Least as Good as Tritanrix™-HepB/Hiberix™ Without Hepatitis B Vaccine at Birth, When Given to Healthy InfantsCompletedNCT00290303Phase 3
- Assess Feasibility of an Acellular Pertussis Vaccine (Pa) Given Soon After Birth, Followed by 3-dose Primary Vaccination With the DTPa-HBV-IPV/Hib VaccineCompletedNCT00289796Phase 2
- Safety Study of HBV DNA Vaccine to Treat Patients With Chronic Hepatitis B InfectionCompletedNCT00277576Phase 1
- Interferon Alpha 2b Plus Ribavirin for Chronic Hepatitis BCompletedNCT00275938Phase 2/3
- A Comparison of the Drug Telbivudine (LdT) and Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis.CompletedNCT00275652Phase 3
- Safety and Effectiveness of an Adjuvant in Improving Immune Response to Hepatitis B Virus Vaccine in HIV Infected IndividualsCompletedNCT00272493Phase 2
- Evaluation of Chronic HBV Patients w/Evidence of HBV Replication and Normal or Minimally Elevated Liver Transaminases.CompletedNCT00263614
- A Comparative Study for Non-Hodgkin's Lymphoma in Hepatitis B Virus CarriersCompletedNCT00262210Phase 2
- Dose-Ranging Study of Pradefovir in Patients With Compensated Hepatitis BCompletedNCT00230503Phase 2
- Open-label Treatment Extension Study for Patients Who Complete Study RNA200103-201TerminatedNCT00230490Phase 2
- Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALTCompletedNCT00230477Phase 4
- Hepatitis B Vaccination in HIV-infected PersonsCompletedNCT00230061Phase 4
- HepeX-B in Post Hepatic Allografts for Treatment of End Stage Liver Disease Due to Hepatitis B InfectionTerminatedNCT00228592Phase 2
- Different Regimens of Pegylated Interferon and Lamivudine Combination Therapy in Chronic Hepatitis B PatientsCompletedNCT00226447Phase 2
- Treatment With Peginterferon Alfa-2a (40 KD) of Chronic Hepatitis B Patients, Who Have Failed Anti-viral TreatmentCompletedNCT00226382Phase 4
- 4-Methylumbelliferone as a Treatment for Chronic HBV/HCVStatus unknownNCT00225537Phase 2
- Qidong Hepatitis B Intervention StudyCompletedNCT00222664Phase 4
- Efficacy and Safety of PegIFN +/- FTC / TDF to Treat Chronic Hepatitis B in HIV-Coinfected PatientsTerminatedNCT00221286Phase 3
- Pilot Safety Study to Determine the Ability of the Protector Cap Jet Injector to Prevent Cross-ContaminationCompletedNCT00219453Phase 1
- A Randomized Study in Non-Hodgkin's Lymphoma Patients Carrying Hepatitis B Surface AntigenCompletedNCT00201318Phase 2
- Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2aCompletedNCT00199732
- Lot-to-lot Consistency of Tritanrix™-HepB/Hib-MenAC & Its Non-inferiority vs Tritanrix™-HepB/Hiberix™ in InfantsCompletedNCT00197275Phase 3
- Long Term F/U Studies at Y5&6 to Demonstrate the Equivalence of 2 Vaccination Schedules of Combined Hepatitis A & B VaccineCompletedNCT00197171Phase 3
- Comparison of Monodose and Multidose Presentations of GSK Biologicals' Hepatitis B Vaccine in Terms of Immune ResponseCompletedNCT00197158Phase 4
- Tenofovir in HIV/HBV CoinfectionCompletedNCT00192595Phase 4
- Insulin Resistance Associated With Chronic Hepatitis C (CHC) and the Effect of Antiviral TherapyStatus unknownNCT00188240Not applicable
- Neurocognitive Functioning in Patients With Hepatitis C Pre- and Post-Treatment With Antiviral MedicationStatus unknownNCT00188201
- Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis PatientsCompletedNCT00186836Phase 4
- Optimizing Hepatitis B Vaccine Response Through the Use of a Topical Immune ModulatorCompletedNCT00175435Phase 1/2
- Antibody Response and Immune Memory 15-18 Years After HBV VaccinationStatus unknownNCT00172328Not applicable
- Long Term Immunogenicity Study of Engerix-B Vaccine in 10 Year Old Children and the Effect of Booster InjectionsCompletedNCT00169858Phase 4
- Cellular Immune Responses to Hepatitis B Virus (HBV)- Longitudinal Follow up and Natural HistoryCompletedNCT00168194